Abnormality of the outer ear
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Acute Myeloid Leukemia (AML-M2)
|
0.300 |
Biomarker
|
disease |
CTD_human |
Discovery of epigenetically silenced genes in acute myeloid leukemias.
|
17330099 |
2007 |
Acute Myeloid Leukemia, M1
|
0.300 |
Biomarker
|
disease |
CTD_human |
Discovery of epigenetically silenced genes in acute myeloid leukemias.
|
17330099 |
2007 |
ANTERIOR SEGMENT DYSGENESIS 7
|
0.700 |
GermlineCausalMutation
|
disease |
ORPHANET |
Novel mutations in PXDN cause microphthalmia and anterior segment dysgenesis.
|
24939590 |
2015 |
ANTERIOR SEGMENT DYSGENESIS 7
|
0.700 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Novel mutations in PXDN cause microphthalmia and anterior segment dysgenesis.
|
24939590 |
2015 |
ANTERIOR SEGMENT DYSGENESIS 7
|
0.700 |
GermlineCausalMutation
|
disease |
ORPHANET |
Homozygous mutations in PXDN cause congenital cataract, corneal opacity, and developmental glaucoma.
|
21907015 |
2011 |
ANTERIOR SEGMENT DYSGENESIS 7
|
0.700 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
ANTERIOR SEGMENT DYSGENESIS 7
|
0.700 |
GeneticVariation
|
disease |
UNIPROT |
Homozygous mutations in PXDN cause congenital cataract, corneal opacity, and developmental glaucoma.
|
21907015 |
2011 |
Anterior segment mesenchymal dysgenesis
|
0.400 |
Biomarker
|
disease |
CTD_human |
|
|
|
Anterior segment mesenchymal dysgenesis
|
0.400 |
GeneticVariation
|
disease |
CLINVAR |
|
|
|
Anti-Glomerular Basement Membrane Disease
|
0.010 |
Biomarker
|
disease |
BEFREE |
We determined whether autoantibodies directed against peroxidasin are also detected in GP.
|
30279272 |
2018 |
Aortic Aneurysm, Abdominal
|
0.010 |
Biomarker
|
disease |
BEFREE |
VPO1 Modulates Vascular Smooth Muscle Cell Phenotypic Switch by Activating Extracellular Signal-regulated Kinase 1/2 (ERK 1/2) in Abdominal Aortic Aneurysms.
|
30371171 |
2018 |
Autistic Disorder
|
0.010 |
Biomarker
|
disease |
BEFREE |
Results from this study indicate that the 2p25.3 duplication disrupting PXDN and MYT1L is a potential autism-causing variant in the pedigree reported here and should receive further consideration as a candidate for autism.
|
22157634 |
2012 |
Bilateral microphthalmos
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
We re-examined exome data from 20 other patients with structural eye defects and identified two additional PXDN mutations in a sporadic male with bilateral microphthalmia, cataracts and anterior segment dysgenesis--a maternally inherited, frameshift mutation, c.1192delT, predicting p.(Tyr398Thrfs*40) and a paternally inherited, missense substitution that was predicted to be deleterious, c.947 A>C, predicting p.(Gln316Pro).
|
24939590 |
2015 |
Blood Protein Measurement
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Co-regulatory networks of human serum proteins link genetics to disease.
|
30072576 |
2018 |
Body Height
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Leveraging Polygenic Functional Enrichment to Improve GWAS Power.
|
30595370 |
2019 |
Carcinoma of lung
|
0.010 |
Biomarker
|
disease |
BEFREE |
We identified a novel 8.1-kb human melanoma gene, MG50, derived from subtractive hybridization with a squamous lung carcinoma cell line, LU-1.
|
11103812 |
2000 |
Carcinoma, Ovarian Epithelial
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
PXDN was highly expressed in OC tissues and cells.
|
29661721 |
2018 |
Cardiac fibrosis
|
0.010 |
Biomarker
|
disease |
BEFREE |
Thus, we conclude that VPO1 is a crucial regulator of cardiac fibrosis after MI by mediating HOCl/Smad2/3 and ERK1/2 signaling pathways, implying a promising therapeutic target in ischemic cardiomyopathy.
|
30844643 |
2019 |
Cardiovascular Diseases
|
0.020 |
Biomarker
|
group |
BEFREE |
Previous studies have demonstrated that NADPH oxidase (NOX)/vascular peroxidase (VPO1) pathway - mediated oxidative stress plays an important role in the pathogenesis of multiple cardiovascular diseases.
|
31216444 |
2019 |
Cardiovascular Diseases
|
0.020 |
AlteredExpression
|
group |
BEFREE |
Aberrant PXDN expression has been associated with kidney fibrosis, cancer, congenital eye defects and various cardiovascular disorders.
|
29953917 |
2018 |
Chronic Kidney Diseases
|
0.010 |
Biomarker
|
group |
BEFREE |
These findings point to EPX and PXDN as potential therapeutic targets for renal fibrosis and CKD and suggest that eosinophils modulate the response to renal injury.
|
30565999 |
2019 |
Chronic Obstructive Airway Disease
|
0.010 |
Biomarker
|
disease |
BEFREE |
The NADPH oxidase-ROS-NF-κB transduction pathway, VPO1, oxidative stress and their complicated interactions are implicated in the occurrence and development of COPD combined with PH.
|
28829513 |
2017 |
Congenital cataract
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
Here, we report homozygous mutations in peroxidasin (PXDN) in two consanguineous Pakistani families with congenital cataract-microcornea with mild to moderate corneal opacity and in a consanguineous Cambodian family with developmental glaucoma and severe corneal opacification.
|
21907015 |
2011 |
Congenital cataract
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
Mutations in PXDN were previously reported in three families with congenital cataracts, microcornea, sclerocornea and developmental glaucoma.
|
24939590 |
2015 |